You are currently viewing a new version of our website. To view the old version click .
Cancers
  • Correction
  • Open Access

12 August 2024

Correction: Flammang et al. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693

,
,
,
,
and
1
Department of General, Visceral and Transplantation Surgery, University Hospital Muenster, Albert-Schweitzer-Campus 1 (W1), 48149 Muenster, Germany
2
Department of Physiological Chemistry and Pathobiochemistry, University of Muenster, Waldeyerstrasse 15, 48149 Muenster, Germany
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
This article belongs to the Section Molecular Cancer Biology

1. Missing Funding

In the original publication [1], the research award of the Maria Moeller Foundation (no Grant Number) to Anda J. Ströse was not included.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

2. Addition of an Author

Anda J. Ströse was not included as an author in the original publication. The corrected Author Contributions Statement appears here.
Anda J. Ströse was involved in the conceptualization, project administration, investigation, and methodology, in the data curation, formal analysis, visualization, in the writing—original draft preparation of a first withdrawn manuscript, and in the funding acquisition by the Maria Moeller Stiftung, Muenster Germany.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Author Contributions

Conceptualization, S.A.D., I.F., M.R. and A.J.S.; methodology, M.R., S.A.D., I.F. and A.J.S.; validation, S.A.D., I.F., M.R.; formal analysis, M.R., I.F., Z.Y., S.A.D. and A.J.S.; investigation, I.F., M.R., S.A.D., Z.Y. J.A.E. and A.J.S.; resources, S.A.D.; data curation, I.F., S.A.D., M.R. and A.J.S.; writing—original draft preparation, I.F., S.A.D., M.R. and A.J.S.; writing—review and editing, I.F., M.R., S.A.D., Z.Y., J.A.E.; visualization, M.R., I.F. and A.J.S.; supervision, S.A.D.; project administration, S.A.D. and A.J.S.; funding acquisition, S.A.D. and A.J.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received external funding by the Maria Moeller Stiftung, Muenster, Germany (no Grant Number). Research on exosomal miRNAs as non-invasive biomarkers in PDAC was partly funded by a research grant of the Maria Moeller Stiftung, Muenster, Germany awarded to Anda J. Ströse. The material reflects only the authors’ point of view and funding partners are not liable for any use that may be made of the information contained therein.

Reference

  1. Flammang, I.; Reese, M.; Ströse, A.J.; Yang, Z.; Eble, J.A.; Dhayat, S.A. Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma. Cancers 2020, 12, 1693. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.